COVID-19 Vaccine & Monoclonal Antibody Products: Changes for MA Plan Claims Start January 1

Mary Madison, RN, RAC-CT, CDP 
Clinical Consultant – Briggs Healthcare

If you vaccinate or administer monoclonal antibody treatment to patients enrolled in Medicare Advantage (MA) plans on or after January 1, 2022, submit claims to the MA Plan. Original Medicare won’t pay these claims.

For more information, consult these resource websites: